MedPath

Disulfiram

Generic Name
Disulfiram
Brand Names
Antabuse
Drug Type
Small Molecule
Chemical Formula
C10H20N2S4
CAS Number
97-77-8
Unique Ingredient Identifier
TR3MLJ1UAI

Overview

A carbamate derivative used as an alcohol deterrent. It is a relatively nontoxic substance when administered alone, but markedly alters the intermediary metabolism of alcohol. When alcohol is ingested after administration of disulfiram, blood acetaldehyde concentrations are increased, followed by flushing, systemic vasodilation, respiratory difficulties, nausea, hypotension, and other symptoms (acetaldehyde syndrome). It acts by inhibiting aldehyde dehydrogenase.

Background

A carbamate derivative used as an alcohol deterrent. It is a relatively nontoxic substance when administered alone, but markedly alters the intermediary metabolism of alcohol. When alcohol is ingested after administration of disulfiram, blood acetaldehyde concentrations are increased, followed by flushing, systemic vasodilation, respiratory difficulties, nausea, hypotension, and other symptoms (acetaldehyde syndrome). It acts by inhibiting aldehyde dehydrogenase.

Indication

For the treatment and management of chronic alcoholism

Associated Conditions

  • Chronic Alcoholism

Clinical Trials

FDA Approved Products

Disulfiram
Manufacturer:Chartwell RX, LLC
Route:ORAL
Strength:250 mg in 1 1
Approved: 2023/10/05
NDC:62135-431
Disulfiram
Manufacturer:Sigmapharm Laboratories, LLC
Route:ORAL
Strength:500 mg in 1 1
Approved: 2022/01/11
NDC:42794-029
Disulfiram
Manufacturer:Golden State Medical Supply, Inc.
Route:ORAL
Strength:250 mg in 1 1
Approved: 2023/12/19
NDC:60429-196
Disulfiram
Manufacturer:Carilion Materials Management
Route:ORAL
Strength:250 mg in 1 1
Approved: 2013/12/30
NDC:68151-2694
Antabuse
Manufacturer:Physicians Total Care, Inc.
Route:ORAL
Strength:250 mg in 1 1
Approved: 2012/04/18
NDC:54868-5034

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath